Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors

References

• Lu LC, Bludau J. Alzheimer’s disease. Santa Barbara: Greenwood Publishing Group; 2011
   Google Scholar
• Ballard C, Gauthier S, Corbett A, et al. Alzheimer’s disease. Lancet 2011;377:1019–31
   PubMed Web of Science ®Google Scholar
• Amemori T, Jendelova P, Ruzicka J, et al. Alzheimer’s disease: mechanism and approach to cell therapy. Int J Mol Sci 2015;16:26417–51
   PubMed Web of Science ®Google Scholar
• Sun ZQ, Tu LX, Zhuo FJ, Liu SX. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer’s. Bioorg Med Chem Lett 2016;26:747–50
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement 2015;11:332–84
   PubMed Web of Science ®Google Scholar
• Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res 2011;221:334–40
   PubMed Web of Science ®Google Scholar
• Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408–14
   PubMed Web of Science ®Google Scholar
• Colović MB, Krstić DZ, Lazarević-Pašti TD, et al. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 2013;11:315–35
   PubMed Web of Science ®Google Scholar
• Groner E, Ashani Y, Schorer-Apelbaum D, et al. The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates. Mol Pharmacol 2007;71:1610–17
   PubMed Web of Science ®Google Scholar
• Greig NH, Utsuki T, Yu Q, et al. A new therapeutic target in Alzheimer’s disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin 2001;17:159–65
   PubMed Web of Science ®Google Scholar
• Schwarz S, Lucas SD, Sommerwerk S, Csuk R. Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases. Bioorg Med Chem 2014;22:3370–8
   PubMed Web of Science ®Google Scholar
• Saeed A, Mahesar PA, Zaib S, et al. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases. Eur J Med Chem 2014;78:43–53
   PubMed Web of Science ®Google Scholar
• Soreq H, Seidman S. Acetylcholinesterase – new roles for an old actor. Nat Rev Neurosci 2001;2:294–302
   PubMed Web of Science ®Google Scholar
• Aurbek N, Thiermann H, Eyer F, et al. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Toxicology 2009;259:133–9
   PubMed Web of Science ®Google Scholar
• Kovarik Z, Katalinić M, Sinko G, et al. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Chem Biol Interact 2010;187:167–71
   PubMed Web of Science ®Google Scholar
• Benzi G, Moretti A. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer’s disease? Eur J Pharmacol 1998;346:1–13
   PubMed Web of Science ®Google Scholar
• Kandemirli F, Saraçoglu M, Kovalishyn V. Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study. Mini Rev Med Chem 2005;5:479–87
   PubMed Web of Science ®Google Scholar
• Onor ML, Trevisiol M, Aguglia E. Rivastigmine in the treatment of Alzheimer’s disease: an update. Clin Interv Aging 2007;2:17–32
   PubMed Web of Science ®Google Scholar
• Cacabelos R. Donepezil in Alzheimer’s disease: from conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat 2007;3:303–33
   PubMedGoogle Scholar
• Giacobini E. Cholinesterase inhibitors: from Calabar bean to Alzheimer therapy. In: Giacobini E, ed. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz; 2000:181–226
   Google Scholar
• Mesulam MM, Guillozet A, Shaw P, et al. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 2002;110:627–39
   PubMed Web of Science ®Google Scholar
• Ballard CG. Advances in the treatment of Alzheimer’s disease: benefits of dual cholinesterase inhibition. Eur Neurol 2002;47:64–70
   PubMed Web of Science ®Google Scholar
• Mushtaq G, Greig NH, Khan JA, Kamal MA. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets 2014;13:1432–9
   PubMed Web of Science ®Google Scholar
• Greig NH, Utsuki T, Ingram DK, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci U S A 2005;47:17213–18
   Web of Science ®Google Scholar
• Giacobini E. Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 2004;50:433–40
   PubMed Web of Science ®Google Scholar
• Cherif O, Allouche F, Chabchoub F, et al. Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer’s disease. Future Med Chem 2014;6:1883–91
   PubMed Web of Science ®Google Scholar
• Brus B, Košak U, Turk S, et al. Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. J Med Chem 2014;57:8167–79
   PubMed Web of Science ®Google Scholar
• Zeb A, Hameed A, Khan L, et al. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors. Med Chem 2014;10:724–9
   PubMed Web of Science ®Google Scholar
• Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep 2011;155:219–29
   PubMed Web of Science ®Google Scholar
• Heinig R, Zimmer D, Yeh S, Krol GJ. Development, validation and application of assays to quantify metrifonate and 2,2-dichlorovinyl dimethylphosphate in human body fluids. J Chromatogr B Biomed Sci Appl 2000;741:257–69
   PubMed Web of Science ®Google Scholar
• Ibach B, Haen E. Acetylcholinesterase inhibition in Alzheimer’s disease. Curr Pharm Des 2004;10:231–51
   PubMed Web of Science ®Google Scholar
• Štěpánková Š, Komers K. Cholinesterases and cholinesterase inhibitors. Curr Enz Inhib 2008;4:160–71
   Google Scholar
• O'neil MJ. The Merck index. 13th ed. New Jersey: Merck & Co., Inc.; 2001
   Google Scholar
• Jann MW. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer’s disease. Pharmacotherapy 2000;20:1–12
   PubMed Web of Science ®Google Scholar
• Sawatzky E, Wehle S, Kling B, et al. Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode. J Med Chem 2016;59:2067–82
   PubMed Web of Science ®Google Scholar
• Liew KF, Chan KL, Lee CY. Blood-brain barrier permeable anticholinesterase aurones: synthesis, structure-activity relationship, and drug-like properties. Eur J Med Chem 2015;94:195–210
   PubMed Web of Science ®Google Scholar
• Bohn P, Gourand F, Papamicaël C, et al. Dihydroquinoline carbamate derivatives as “bio-oxidizable” prodrugs for brain delivery of acetylcholinesterase inhibitors: [11C] radiosynthesis and biological evaluation. ACS Chem Neurosci 2015;6:737–44
   PubMed Web of Science ®Google Scholar
• Sedlák M, Hanusek J, Drabina P, et al. Substituted benzyl N-phenylcarbamates – their solvolysis and inhibition activity to acetylcholinesterase and butyrylcholinesterase. Arkivoc 2009;vii:1–11
   Google Scholar
• Imramovský A, Pejchal V, Štěpánková Š, et al. Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors. Bioorg Med Chem 2013;21:1735–48
   PubMed Web of Science ®Google Scholar
• Vorčáková K, Štěpánková Š, Sedlák M, Vytřas K. Electrochemical sensors for the estimation of the inhibitory effect of phenylcarbamates to cholinesterase. Chemosensors 2015;3:274–83
   Web of Science ®Google Scholar
• Saxena J, Meloni D, Huang MT, et al. Ethynylphenyl carbonates and carbamates as dual-action acetylcholinesterase inhibitors and anti-inflammatory agents. Bioorg Med Chem Lett 2015;25:5609–12
   PubMed Web of Science ®Google Scholar
• Camerino E, Wong DM, Tong F, et al. Difluoromethyl ketones: potent inhibitors of wild type and carbamate-insensitive G119S mutant Anopheles gambiae acetylcholinesterase. Bioorg Med Chem Lett 2015;25:4405–11
   PubMed Web of Science ®Google Scholar
• Verma A, Wong DM, Islam R, et al. 3-Oxoisoxazole-2(3H)-carboxamides and isoxazol-3-yl carbamates: resistance-breaking acetylcholinesterase inhibitors targeting the malaria mosquito, Anopheles gambiae. Bioorg Med Chem 2015;23:1321–40
   PubMed Web of Science ®Google Scholar
• Anand P, Singh B. Synthesis and evaluation of substituted 4-methyl-2-oxo-2H-chromen-7-yl phenyl carbamates as potent acetylcholinesterase inhibitors and anti-amnestic agents. Med Chem 2013;9:694–702
   PubMed Web of Science ®Google Scholar
• Anand P, Singh B. Synthesis and evaluation of novel carbamate substituted flavanone derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents. Med Chem Res 2013;22:1648–59
   Web of Science ®Google Scholar
• Ma H-J, Xie RL, Zhao QF, et al. Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors. J Agric Food Chem 2010;58:12817–21
   PubMed Web of Science ®Google Scholar
• León R, Garcia AG, Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease. Med Res Rev 2013;33:139–89
   PubMed Web of Science ®Google Scholar
• Gnad F, Reiser O. Synthesis and applications of beta-aminocarboxylic acids containing a cyclopropane ring. Chem Rev 2003;103:1603–24
   PubMed Web of Science ®Google Scholar
• Rappopot Z, ed. The chemistry of the cyclopropyl group vol. 1–2. New York: Wiley-VCH; 1987
   Google Scholar
• Tedeschi RE. Monoamine oxidase inhibition, US Patent 2,997,422; 1961
   Google Scholar
• Sangster JJ. Octanol-water partition coefficients of simple organic compounds. Phys Chem Ref Data 1989;18:1111–227
   Web of Science ®Google Scholar
• OECD Guidelines for the Testing of Chemicals, Section 1, Books / OECD Guidelines for the Testing of Chemicals, Section 1/Test No. 107: Partition Coefficient (n-octanol/water): Shake Flask Method; [cited 2016 Jul 18]. Available from: http://www.oecd-ilibrary.org/environment/test-no-107-partition-coefficient-n-octanol-water-shake-flask-method_9789264069626-en
   Google Scholar
• Havelek R, Siman P, Cmielova J, et al. Differences in vanadocene dichloride and cisplatin effect on MOLT-4 leukemia and human peripheral blood mononuclear cells. Med Chem 2012;8:615–21
   PubMed Web of Science ®Google Scholar
• Berthod A, Carda-Broch S. Determination of liquid-liquid partition coefficients by separation methods. J Chromatogr A 2004;1037:3–14
   PubMed Web of Science ®Google Scholar
• Burger A, Yost WL. Arylcycloalkylamines. I. 2-Phenylcyclopropylamine. J Am Chem Soc 1948;70:2198–201
   Web of Science ®Google Scholar
• Evans DA, Woerpel KA, Hinman MM, Faul MM. Bis(oxazolines) as chiral ligands in metal-catalyzed asymmetric reactions. Catalytic, asymmetric cyclopropanation of olefins. J Am Chem Soc 1991;113:726–8
   Web of Science ®Google Scholar
• Tsai TY, Hsu T, Chen CT, et al. Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors. Bioorg Med Chem 2009;17:2388–99
   PubMed Web of Science ®Google Scholar
• Ninomiya K, Shioiri T, Yamada S. Phosphorus in organic synthesis – VII: diphenyl phosphorazidate (DPPA). A new convenient reagent for a modified curtius reaction. Tetrahedron 1974;30:2151–7
   Web of Science ®Google Scholar
• Fernández C, Nieto O, Fontenla JA, et al. Synthesis of glycosyl derivatives as dopamine prodrugs: interaction with glucose carrier GLUT-1. Org Biomol Chem 2003;1:767–71
   PubMed Web of Science ®Google Scholar
• Calvaresi EC, Hergenrother PJ. Glucose conjugation for the specific targeting and treatment of cancer. Chem Sci 2013;4:2319–33
   PubMed Web of Science ®Google Scholar
• Uriel C, Egron MJ, Santarromana M, et al. Hexose keto-C-glycoside conjugates: design, synthesis, cytotoxicity, and evaluation of their affinity for the glucose transporter Glut-1. Bioorg Med Chem 1996;4:2081–90
   PubMed Web of Science ®Google Scholar
• Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 2001;18:247–56
   PubMed Web of Science ®Google Scholar
• Shakeel UR, Khursheed AB, Shabir HL, Fayaz AM. Click chemistry inspired facile synthesis and bioevaluation of novel triazolyl analogs of D-(+)-pinitol. Arab J Chem 2015. [Epub ahead of print]. doi:10.1016/j.arabjc.2015.10.009
   Google Scholar
• Leo A, Hansch C, Elkins D. Partition coefficients and their uses. Chem Rev 1971;71:525–616
   Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–41
   PubMedGoogle Scholar
• Ellman GL, Courtney KD, Andres V, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95
   PubMed Web of Science ®Google Scholar
• Ou S, Kwok KC, Wang Y, Bao H. An improved method to determine SH and -S-S- group content in soymilk protein. Food Chem 2004;88:317–20
   Web of Science ®Google Scholar